维普中文期刊产品整合服务
17篇 您的检索式:作者名="Jensterle M"
    题名 作者 年代 出处 被引量
1Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing puten- tial of liraglutide in obese polycystic ovary syndrome: random- ized control study显示文摘Jensterle M Goricar K Janez A 2016Exp Ther Meal2016,11,4:1
2Interrelationship between peripheral arterial occlusive disease caratid atherosclerosis and flow mediated dilation of the brachial artery显示文摘POREDOS P GOLOB M JENSTERLE M 2003International Angiology2003,22,1:1
3Assessment of insulin resistance in young women with polycystic ovary syn drome显示文摘Jensterle M Weber M Pfeifer M el al 2008Int J Gynaecol Obstet2008,102,2:1
4Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome显示文摘Jensterle M Janez A Mlinar B 2008Eur J Endocrinol2008,158,:1
5Expression of 11 p-hydrox-ysteroid dehydrogenase type 1 in visceral and subcutaneous adi-pose tissues of patients with polycystic ovary syndrome is associat-ed with adiposity 显示文摘Mlinar B Marc J Jensterle M 2011J Steroid Biochem Mol Biol2011,123,35:1
6Interrelationship between peripheral arterial occlusive disease,carotid atherosclerosis and flow mediated dilation of the brachial artery显示文摘Paredos P Golob M Jensterle M 2003Inter Angiology2003,22,1:1
7Short -tcrm combined treatment with liraglutide and metformin leads o significant weight loss in obese women with polycystic ova- y syndrome and previous poor response to metformin 显示文摘Jensterle Sever M Koejan T Pfeifer M 2014Eur J Endocrinol2014,170,3:1
8Phosphodiesterase 4 inhibition as a potential new therapeutic target in obese women with polycystic ovary syndrome显示文摘Jensterle M Kocjan T Janez A 2014J Clin Endocrinol Metab2014,99,8:1
9Assessment of insulin resistance in young women with polycystic ovary syndrome显示文摘Jensterle M Weber M Pfeifer M 2008Int J Gynaecol Obstet2008,102,2:1
10Short-term com- bined treatment with liraglutide and metformin leads to signifi- cant weight Loss in obese women with polycystic ovary syn- drome and previous poor response to metformin显示文摘Jensterle Sever M Kocjan T Pfeifer M 2014Eur J En- docrinol2014,170,3:1
11Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome显示文摘Steiner CA Janez A Jensterle M 2007J Diabetes Sci Technol2007,1,2:1
12Improvement of en-dothelial function with metformin and rosiglitazone treatmentin women with polycystic ovary syndrome 显示文摘Jensterle M Sebestjen M Janez A 2008Eur J En-docrinol2008,159,4:1
13A 12 -weektreatment with the long-acting glucagon-like peptide 1 re-ceptor agonist liraglutide leads to significant weight loss in asubset of obese women with newly diagnosed polycystic o-vary syndrome显示文摘Jensterle M Kravos NA Pfeifer M 2015Hormones (Athens)2015,14,1:1
14Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome显示文摘Jensterle M Janez A Mlinar B 2008Eur J Endocrinol2008,158,6:1
15, Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syn- drome 显示文摘Jensterle M Jabez AmNkubar B 2008Eur Endocrinology2008,158,6:1
16A 12 -week treatment with the long - acting glucagon - like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polyeystic ovary syndrome 显示文摘Jensterle M Kravos NA Pfeifer M 2015Hor- mones ( Athens)2015,14,1:1
17Short- term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with poIy- cystic ovary syndrome and previous poor response to met- {ormin显示文摘SM JENSTERLE T KOCJAN M PFEIFER 2014Eur J Endoerino|2014,170,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费